Thomas Story & Son LLC Abbott Laboratories Transaction History
Thomas Story & Son LLC
- $237 Million
- Q1 2024
A detailed history of Thomas Story & Son LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Thomas Story & Son LLC holds 52,825 shares of ABT stock, worth $5.53 Million. This represents 2.54% of its overall portfolio holdings.
Number of Shares
52,825
Previous 52,825
-0.0%
Holding current value
$5.53 Million
Previous $5.81 Million
3.27%
% of portfolio
2.54%
Previous 2.73%
Shares
17 transactions
Others Institutions Holding ABT
# of Institutions
3,111Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.19M-
Vanguard Group Inc Valley Forge, PA165MShares$17.3 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.9 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.8 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.83 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.35 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $183B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...